Cargando…

Unusual architecture of the p7 channel from hepatitis C virus

The Hepatitis C virus (HCV) has developed a small membrane protein, p7, which remarkably can self-assemble into a large channel complex that selectively conducts cations(1-4). We are curious as to what structural solution has the viroporin adopted to afford selective cation conduction because p7 has...

Descripción completa

Detalles Bibliográficos
Autores principales: OuYang, Bo, Xie, Shiqi, Berardi, Marcelo J., Zhao, Xinhao, Dev, Jyoti, Yu, Wenjing, Sun, Bing, Chou, James J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725310/
https://www.ncbi.nlm.nih.gov/pubmed/23739335
http://dx.doi.org/10.1038/nature12283
_version_ 1782476778265116672
author OuYang, Bo
Xie, Shiqi
Berardi, Marcelo J.
Zhao, Xinhao
Dev, Jyoti
Yu, Wenjing
Sun, Bing
Chou, James J.
author_facet OuYang, Bo
Xie, Shiqi
Berardi, Marcelo J.
Zhao, Xinhao
Dev, Jyoti
Yu, Wenjing
Sun, Bing
Chou, James J.
author_sort OuYang, Bo
collection PubMed
description The Hepatitis C virus (HCV) has developed a small membrane protein, p7, which remarkably can self-assemble into a large channel complex that selectively conducts cations(1-4). We are curious as to what structural solution has the viroporin adopted to afford selective cation conduction because p7 has no homology with any of the known prokaryotic or eukaryotic channel proteins. The p7 activity can be inhibited by amantadine and rimantadine(2,5), which also happen to be potent blockers of the influenza M2 channel(6) and licensed drugs against influenza infections(7). The adamantane derivatives were subjects of HCV clinical trials(8), but large variation in drug efficacy among the various HCV genotypes has been difficult to explain without detailed molecular structures. Here, we determined the structures of this HCV viroporin as well as its drug-binding site using the latest nuclear magnetic resonance (NMR) technologies. The structure exhibits an unusual mode of hexameric assembly, where the individual p7 monomers, i, not only interact with their immediate neighbors, but also reach farther to associate with the i+2 and i+3 monomers, forming a sophisticated, funnel-like architecture. The structure also alludes to a mechanism of cation selection: an asparagine/histidine ring that constricts the narrow end of the funnel serves as a broad cation selectivity filter while an arginine/lysine ring that defines the wide end of the funnel may selectively allow cation diffusion into the channel. Our functional investigation using whole-cell channel recording showed that these residues are indeed critical for channel activity. NMR measurements of the channel-drug complex revealed six equivalent hydrophobic pockets between the peripheral and pore-forming helices to which amantadine or rimantadine binds, and compound binding specifically to this position may allosterically inhibit cation conduction by preventing the channel from opening. Our data provide molecular explanation for p7-mediated cation conductance and its inhibition by adamantane derivatives.
format Online
Article
Text
id pubmed-3725310
institution National Center for Biotechnology Information
language English
publishDate 2013
record_format MEDLINE/PubMed
spelling pubmed-37253102013-12-27 Unusual architecture of the p7 channel from hepatitis C virus OuYang, Bo Xie, Shiqi Berardi, Marcelo J. Zhao, Xinhao Dev, Jyoti Yu, Wenjing Sun, Bing Chou, James J. Nature Article The Hepatitis C virus (HCV) has developed a small membrane protein, p7, which remarkably can self-assemble into a large channel complex that selectively conducts cations(1-4). We are curious as to what structural solution has the viroporin adopted to afford selective cation conduction because p7 has no homology with any of the known prokaryotic or eukaryotic channel proteins. The p7 activity can be inhibited by amantadine and rimantadine(2,5), which also happen to be potent blockers of the influenza M2 channel(6) and licensed drugs against influenza infections(7). The adamantane derivatives were subjects of HCV clinical trials(8), but large variation in drug efficacy among the various HCV genotypes has been difficult to explain without detailed molecular structures. Here, we determined the structures of this HCV viroporin as well as its drug-binding site using the latest nuclear magnetic resonance (NMR) technologies. The structure exhibits an unusual mode of hexameric assembly, where the individual p7 monomers, i, not only interact with their immediate neighbors, but also reach farther to associate with the i+2 and i+3 monomers, forming a sophisticated, funnel-like architecture. The structure also alludes to a mechanism of cation selection: an asparagine/histidine ring that constricts the narrow end of the funnel serves as a broad cation selectivity filter while an arginine/lysine ring that defines the wide end of the funnel may selectively allow cation diffusion into the channel. Our functional investigation using whole-cell channel recording showed that these residues are indeed critical for channel activity. NMR measurements of the channel-drug complex revealed six equivalent hydrophobic pockets between the peripheral and pore-forming helices to which amantadine or rimantadine binds, and compound binding specifically to this position may allosterically inhibit cation conduction by preventing the channel from opening. Our data provide molecular explanation for p7-mediated cation conductance and its inhibition by adamantane derivatives. 2013-06-05 2013-06-27 /pmc/articles/PMC3725310/ /pubmed/23739335 http://dx.doi.org/10.1038/nature12283 Text en http://www.nature.com/authors/editorial_policies/license.html#terms Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms
spellingShingle Article
OuYang, Bo
Xie, Shiqi
Berardi, Marcelo J.
Zhao, Xinhao
Dev, Jyoti
Yu, Wenjing
Sun, Bing
Chou, James J.
Unusual architecture of the p7 channel from hepatitis C virus
title Unusual architecture of the p7 channel from hepatitis C virus
title_full Unusual architecture of the p7 channel from hepatitis C virus
title_fullStr Unusual architecture of the p7 channel from hepatitis C virus
title_full_unstemmed Unusual architecture of the p7 channel from hepatitis C virus
title_short Unusual architecture of the p7 channel from hepatitis C virus
title_sort unusual architecture of the p7 channel from hepatitis c virus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3725310/
https://www.ncbi.nlm.nih.gov/pubmed/23739335
http://dx.doi.org/10.1038/nature12283
work_keys_str_mv AT ouyangbo unusualarchitectureofthep7channelfromhepatitiscvirus
AT xieshiqi unusualarchitectureofthep7channelfromhepatitiscvirus
AT berardimarceloj unusualarchitectureofthep7channelfromhepatitiscvirus
AT zhaoxinhao unusualarchitectureofthep7channelfromhepatitiscvirus
AT devjyoti unusualarchitectureofthep7channelfromhepatitiscvirus
AT yuwenjing unusualarchitectureofthep7channelfromhepatitiscvirus
AT sunbing unusualarchitectureofthep7channelfromhepatitiscvirus
AT choujamesj unusualarchitectureofthep7channelfromhepatitiscvirus